Dublin, June 19, 2019 (GLOBE NEWSWIRE) -- The "Injectable Drug Delivery Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.
Injectable drug delivery is considered to be the most effective means of drug delivery into the human body and is thus considered to be the most effective administration route. These are in high demand due to the prevalence of chronic diseases worldwide driving the market growth during the forecast period.
Furthermore, growing R&D activities, growing health expenditure and growing age-related diseases with the increasing elderly population worldwide are also driving the growth of the global injectable drug delivery market in the forecast period.
Report Coverage
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market.
The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions.
Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the injectable drug delivery market.
Major industry players profiled as part of the report are Wilhelm Haselmeier, Owen Mumford, SHL Medical, Enable Injections, and Ypsomed.
Key Topics Covered
1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base & Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Injectable Drug Delivery Market by Device Type
5.1. Needle-Free Injectors
5.2. Patch Injectors
5.3. Auto Injectors
5.4. Others
6. Injectable Drug Delivery Market by Application
6.1. Disease Treatment
6.2. Research/Academic Purposes
7. Injectable Drug Delivery Market by Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. Competitive Intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. Company Profiles
9.1. Wilhelm Haselmeier GmbH & Co. KG
9.2. Owen Mumford Ltd.
9.3. SHL Medical AG
9.4. Enable Injections
9.5. Ypsomed AG
For more information about this report visit https://www.researchandmarkets.com/r/6jj6ot
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.